Kriya Therapeutics’ $270 Million Series C Financing Round

Cooley advised Kriya Therapeutics on the deal.Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing round. …

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now